10 Hep C Stocks on Wall Street's Watch List

Updated:
09.15.11
Views:
User Rating:
0.00/0
TheStreet Rating:
C+
RATE NOW
Log in to rate this portfolio
Follow
Log in to follow

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Add Comment

Add Comment

Most Viewed Portfolios

View All

Articles

5 Stocks Rising on Unusual Volume

06.20.13 | 07:08 AM

MADISON, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track b...

3 Health Care Stocks Spiking on Big Volume

06.20.13 | 07:09 AM

MADISON, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track b...